156 related articles for article (PubMed ID: 33667689)
1. Oligosaccharides from fucosylated glycosaminoglycan prevent breast cancer metastasis in mice by inhibiting heparanase activity and angiogenesis.
Zhou L; Yin R; Gao N; Sun H; Chen D; Cai Y; Ren L; Yang L; Zuo Z; Zhang H; Zhao J
Pharmacol Res; 2021 Apr; 166():105527. PubMed ID: 33667689
[TBL] [Abstract][Full Text] [Related]
2. Specific Inhibition of Heparanase by a Glycopolymer with Well-Defined Sulfation Pattern Prevents Breast Cancer Metastasis in Mice.
Loka RS; Sletten ET; Barash U; Vlodavsky I; Nguyen HM
ACS Appl Mater Interfaces; 2019 Jan; 11(1):244-254. PubMed ID: 30543095
[TBL] [Abstract][Full Text] [Related]
3. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
5. PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model.
Hammond E; Brandt R; Dredge K
PLoS One; 2012; 7(12):e52175. PubMed ID: 23300607
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
7. Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk.
Zhou L; Gao N; Sun H; Xiao C; Yang L; Lin L; Yin R; Li Z; Zhang H; Ji X; Zhao J
Thromb Haemost; 2020 Apr; 120(4):607-619. PubMed ID: 32289860
[TBL] [Abstract][Full Text] [Related]
8. PI-88 and Related Heparan Sulfate Mimetics.
Chhabra M; Ferro V
Adv Exp Med Biol; 2020; 1221():473-491. PubMed ID: 32274723
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
[No Abstract] [Full Text] [Related]
10. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
11. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation.
Ferro V; Hammond E; Fairweather JK
Mini Rev Med Chem; 2004 Aug; 4(6):693-702. PubMed ID: 15279603
[TBL] [Abstract][Full Text] [Related]
12. The components and activities analysis of a novel anticoagulant candidate dHG-5.
Sun H; Gao N; Ren L; Liu S; Lin L; Zheng W; Zhou L; Yin R; Zhao J
Eur J Med Chem; 2020 Dec; 207():112796. PubMed ID: 32942073
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues.
Marchetti D; Reiland J; Erwin B; Roy M
Int J Cancer; 2003 Mar; 104(2):167-74. PubMed ID: 12569571
[TBL] [Abstract][Full Text] [Related]
14. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
15. λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration.
Groult H; Cousin R; Chot-Plassot C; Maura M; Bridiau N; Piot JM; Maugard T; Fruitier-Arnaudin I
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30818840
[TBL] [Abstract][Full Text] [Related]
16. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
17. Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells.
Zheng L; Jiang G; Mei H; Pu J; Dong J; Hou X; Tong Q
BMC Cancer; 2010 Feb; 10():33. PubMed ID: 20137078
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of a selective heparanase inhibitor as an antimetastatic agent.
Ishida K; Hirai G; Murakami K; Teruya T; Simizu S; Sodeoka M; Osada H
Mol Cancer Ther; 2004 Sep; 3(9):1069-77. PubMed ID: 15367701
[TBL] [Abstract][Full Text] [Related]
19. Heparanase, tissue factor, and cancer.
Nadir Y; Vlodavsky I; Brenner B
Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
[TBL] [Abstract][Full Text] [Related]
20. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]